Cargando…

Impact of Fecal Microbiota Transplantation on Gut Bacterial Bile Acid Metabolism in Humans

Fecal microbiota transplantation (FMT) is a promising therapeutic modality for the treatment and prevention of metabolic disease. We previously conducted a double-blind, randomized, placebo-controlled pilot trial of FMT in obese metabolically healthy patients in which we found that FMT enhanced gut...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bustamante, Jessica-Miranda, Dawson, Tyson, Loeffler, Caitlin, Marfori, Zara, Marchesi, Julian R., Mullish, Benjamin H., Thompson, Christopher C., Crandall, Keith A., Rahnavard, Ali, Allegretti, Jessica R., Cummings, Bethany P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9785599/ https://www.ncbi.nlm.nih.gov/pubmed/36558359 http://dx.doi.org/10.3390/nu14245200

Ejemplares similares

The contribution of bile acid metabolism to the pathogenesis of Clostridioides difficile infection
por: Mullish, Benjamin H., et al.
Publicado: (2021)

In Vitro Modeling of Bile Acid Processing by the Human Fecal Microbiota
por: Martin, Glynn, et al.
Publicado: (2018)

Effective fecal microbiota transplantation for recurrent Clostridioides difficile infection in humans is associated with increased signalling in the bile acid-farnesoid X receptor-fibroblast growth factor pathway
por: Monaghan, Tanya, et al.
Publicado: (2018)

The potential utility of fecal (or intestinal) microbiota transplantation in controlling infectious diseases
por: Ghani, Rohma, et al.
Publicado: (2022)

Understanding the mechanisms of efficacy of fecal microbiota transplant in treating recurrent Clostridioides difficile infection and beyond: the contribution of gut microbial-derived metabolites
por: Martinez-Gili, Laura, et al.
Publicado: (2020)

Epidemiological associations with genomic variation in SARS-CoV-2
por: Rahnavard, Ali, et al.
Publicado: (2021)

Insights into the role of fecal microbiota transplantation for the treatment of inflammatory bowel disease
por: Levy, Alexander N., et al.
Publicado: (2019)

Microbial bile salt hydrolases mediate the efficacy of faecal microbiota transplant in the treatment of recurrent Clostridioides difficile infection
por: Mullish, Benjamin H, et al.
Publicado: (2019)

The impact of the COVID-19 pandemic on Clostridioides difficile infection and utilization of fecal microbiota transplantation
por: Bachour, Salam P., et al.
Publicado: (2023)

Short-chain fatty and carboxylic acid changes associated with fecal microbiota transplant communally influence microglial inflammation
por: Churchward, Matthew A., et al.
Publicado: (2023)

Changes in IgA-targeted microbiota following fecal transplantation for recurrent Clostridioides difficile infection
por: Huus, Kelsey E, et al.
Publicado: (2020)

Altered microbiota, fecal lactate, and fecal bile acids in dogs with gastrointestinal disease
por: Blake, Amanda B., et al.
Publicado: (2019)

Long‐term impact of tylosin on fecal microbiota and fecal bile acids of healthy dogs
por: Manchester, Alison C., et al.
Publicado: (2019)

Disease Prevention Not Decolonization: A Model for Fecal Microbiota Transplantation in Patients Colonized With Multidrug-resistant Organisms
por: Ghani, Rohma, et al.
Publicado: (2020)

Meeting update: faecal microbiota transplantation––bench, bedside, courtroom?
por: Ding, Nik Sheng, et al.
Publicado: (2018)

Analysis of fecal bile acids and metabolites by high resolution mass spectrometry in farm animals and correlation with microbiota
por: Porru, Emanuele, et al.
Publicado: (2022)

In search of stool donors: a multicenter study of prior knowledge, perceptions, motivators, and deterrents among potential donors for fecal microbiota transplantation
por: McSweeney, Breanna, et al.
Publicado: (2019)

Expression of Human Endogenous Retroviruses in Systemic Lupus Erythematosus: Multiomic Integration With Gene Expression
por: Stearrett, Nathaniel, et al.
Publicado: (2021)

618. Do Clinical Factors Affect Microbial Engraftment After Fecal Microbiota Transplantation in Recurrent Clostridium difficile Infection?
por: Budree, Shrish, et al.
Publicado: (2018)

Mechanisms underpinning the efficacy of faecal microbiota transplantation in treating gastrointestinal disease
por: Segal, Jonathan P., et al.
Publicado: (2020)

Metabolite, protein, and tissue dysfunction associated with COVID-19 disease severity
por: Rahnavard, Ali, et al.
Publicado: (2022)

533. Scaling Pediatric Access to Fecal Microbiota Transplantation in the United States: A Time-Series Geospatial Analysis
por: Panchal, Pratik, et al.
Publicado: (2018)

Recovery of Fecal Microbiome and Bile Acids in Healthy Dogs after Tylosin Administration with and without Fecal Microbiota Transplantation
por: Marclay, Margaux, et al.
Publicado: (2022)

Fecal Microbiota Transplant Mitigates Adverse Outcomes Seen in Patients Colonized With Multidrug-Resistant Organisms Undergoing Allogeneic Hematopoietic Cell Transplantation
por: Innes, Andrew J., et al.
Publicado: (2021)

The implementation of omics technologies in cancer microbiome research
por: Mullish, Benjamin H, et al.
Publicado: (2018)

Ursodeoxycholic acid enriches intestinal bile salt hydrolase-expressing Bacteroidetes in cholestatic pregnancy
por: Ovadia, Caroline, et al.
Publicado: (2020)

Fecal microbiota and bile acids in IBD patients undergoing screening for colorectal cancer
por: Lavelle, Aonghus, et al.
Publicado: (2022)

Intestinal microbiome transfer, a novel therapeutic strategy for COVID-19 induced hyperinflammation?: In reply to, ‘COVID-19: Immunology and treatment options’, Felsenstein, Herbert McNamara et al. 2020′
por: McIlroy, James R., et al.
Publicado: (2020)

Omics community detection using multi-resolution clustering
por: Rahnavard, Ali, et al.
Publicado: (2021)

Comprehensive Analysis of Gut Microbiota and Fecal Bile Acid Profiles in Children With Biliary Atresia
por: Yang, Ting, et al.
Publicado: (2022)

Small Intestinal Permeability and Metabolomic Profiles in Feces and Plasma Associate With Clinical Response in Patients With Active Psoriatic Arthritis Participating in a Fecal Microbiota Transplantation Trial: Exploratory Findings From the FLORA Trial
por: Kragsnaes, Maja Skov, et al.
Publicado: (2023)

Gaps in knowledge and future directions for the use of faecal microbiota transplant in the treatment of inflammatory bowel disease
por: Yalchin, Mehmet, et al.
Publicado: (2019)

Fecal Bile Salts and the Development of Necrotizing Enterocolitis in Preterm Infants
por: Hulzebos, Christian V., et al.
Publicado: (2017)

Developmental Patterns of Fecal Bile Acids in Healthy Neonates and Children
por: Xiong, Jing-Jing, et al.
Publicado: (2021)

Altered fecal bile acid composition in active ulcerative colitis
por: Sommersberger, Stefanie, et al.
Publicado: (2023)

The application of omics techniques to understand the role of the gut microbiota in inflammatory bowel disease
por: Segal, Jonathan P., et al.
Publicado: (2019)

Bile salt metabolism is not the only factor contributing to Clostridioides (Clostridium) difficile disease severity in the murine model of disease
por: Jukes, Caitlin A., et al.
Publicado: (2019)

Fecal identification markers impact the feline fecal microbiota
por: Nealon, Nora Jean, et al.
Publicado: (2023)

Disordered Gut Microbiota Correlates With Altered Fecal Bile Acid Metabolism and Post-cholecystectomy Diarrhea
por: Xu, Yayun, et al.
Publicado: (2022)

The 7-α-dehydroxylation pathway: An integral component of gut bacterial bile acid metabolism and potential therapeutic target
por: Wise, Journey L., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_mk9r0kvqs8hs88rtpdh975cfmi